Tam Jai International's Pioneering Surplus Pork Belly Upcycling Project Sweeps Multiple Sustainability and PR Awards

by | PRNewswire Asia

First F&B Group with Social Impact Quantified under Nan Fung Group’s Net Positive Lease HONG KONG, Jan. 15, 2026 /PRNewswire/ — Tam Jai International Co. Limited ("TJI" or the "Company", together with its subsidiaries, the...

HJT Shines in Malaysia! Risen Energy Signs New PV Project to Accelerate Layout in Southeast Asia

by | PRNewswire Asia

NINGBO, China, Jan. 15, 2026 /PRNewswire/ — Recently, Risen Energy and Eco Persona, a Malaysian solar EPC enterprise, held a strategic cooperation signing ceremony. Both parties will jointly develop commercial and industrial rooftop photovoltaic projects in the...

YI TING Non-Woven Doubles Capacity for Sustainable Solutions, Strengthening Presence in Europe and North America

by | PRNewswire Asia

(Strategic Expansion Positions YI TING as Resilient Supply Partner, Cutting Lead Times By Up to 30% for Sustainable Filtration) TAOYUAN, Jan. 15, 2026 /PRNewswire/ — Trusted by world-renowned specialty coffee equipment innovators and Tier-1 roasters, YI...

Docquity Launches Engage™, an AI and Insights-Powered HCP Intelligence Engine for the Life Sciences Industry

by | PRNewswire Asia

SINGAPORE, Jan. 15, 2026 /PRNewswire/ — Docquity, a leading health tech company in Asia, today announced the launch of Docquity Engage™, an AI and Insights-powered market intelligence engine designed to help life sciences companies better understand...

International Healthcare Week Returns to Thailand in 2026 with Expanded Industry Reach

by | PRNewswire Asia

BANGKOK, Jan. 15, 2026 /PRNewswire/ — International Healthcare Week is set to return to Thailand (8-10 July 2026, Queen Sirikit National Convention Center, Bangkok), bringing together the region’s most influential health and wellness stakeholders....

AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products

by | PRNewswire Asia

HONG KONG, Jan. 15, 2026 /PRNewswire/ — AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully completed the Phase III...